Abstract
We describe a case of acute hepatic toxicity associated with aerosolized ribavirin in a bone marrow transplant recipient with documented respiratory syncytial virus infection. The temporal relationship with drug administration and the liver biopsy results suggested drug-induced hepatic injury. As the use of aerosolized ribavirin to treat respiratory syncytial virus infections continues, it is imperative that careful attention be paid to possible adverse effects of therapy in the high-risk population of immunosuppressed patients.
Original language | English (US) |
---|---|
Pages (from-to) | e72-75 |
Journal | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |
Volume | 42 |
Issue number | 8 |
DOIs | |
State | Published - Apr 15 2006 |
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases